Safety and efficacy of ALRV5XR in men with androgenetic alopecia: A randomised, double-blinded, placebo-controlled clinical trial

P.R. Feldman*, K.M. Fiebig*, C. Piwko, B.M. Mints, D. Brown, D.J. Cahan, J. Guevara-Aguirre

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number101124
Number of pages11
JournalEClinicalMedicine
Volume40
DOIs
Publication statusPublished - 1 Oct 2021

Keywords

  • ALRV5XR
  • Alopecia
  • Androgenetic alopecia
  • Male pattern hair loss
  • Hair restoration
  • Minoxidil
  • Finasteride
  • Botanical
  • Vitamin
  • Supplement
  • Senescence
  • Ageing
  • Wnt/beta-catenin
  • Stem cell
  • Hair regeneration
  • Regenerative medicine
  • Clinical trial
  • PRP
  • Terminal hair
  • Vellus like hair
  • Terminal vellus ratio
  • HAIR
  • MINOXIDIL

Cite this